Read more about Covishield vaccine being procured by govt at Rs 210 per dose: MoS Health on Business Standard. The Oxford-AstraZeneca vaccine Covishield, manufactured by the Serum Institute of India, is being procured by the government at a lower price of Rs 210 per dose, the Lok Sabha was told on Friday
Read more about China s PLA delivers a batch of coronavirus vaccines to Pakistan Army on Business Standard. Chinese military delivered a batch of COVID-19 vaccines to the Pakistan Army on Sunday, days after Islamabad received 500,000 doses of the coronavirus vaccine from its all-weather ally Beijing.The People s Liberation Army (PLA) said in a statement
By Joseph Choi - 02/07/21 04:32 PM EST
South Africa has stopped the use of the AstraZeneca vaccine after data emerged that showed it provided minimal protection against the South Africa coronavirus variant, which is currently dominant in the country.
Reuters reports that Health Minister Zweli Mkhize made the announcement on Sunday following disappointing results from a trial conducted by the University of the Witwatersrand in Johannesburg.
The outlet reports that the South African government had planned to roll out doses of the AstraZeneca vaccine on Monday but will now offer the vaccines developed by Johnson & Johnson and Pfizer instead.
ADVERTISEMENT
“The AstraZeneca vaccine will remain with us . up until the scientists give us clear indications as to what we need to do,” Mkhize said.
Read more about Oxford-AstraZeneca jab effective against UK Covid variant, study finds on Business Standard. The COVID-19 vaccine developed by Oxford University and produced by AstraZeneca has shown efficacy against the UK variant of the coronavirus, according to an ongoing study by researchers.
Andrew Pollard of Oxford University, which helped develop the AstraZeneca vaccine, says the shot also appears to reduce the amount of virus in people infected with COVID-19